Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Syros Pharmaceuticals Inc. buy BiotechBee

Syros Pharmaceuticals Inc.
Start price
€1.40
08.09.24 / 30%
Target price
€5.50
30.06.27
Performance (%)
25.00%
End price
€1.75
29.09.24
Summary
This prediction ended on 29.09.24 with a price of €1.75. The prediction had a final performance of 25.00%. BiotechBee has 30% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Syros Pharmaceuticals Inc. - - -
iShares Core DAX® -1.212% 1.925% 17.589%
iShares Nasdaq 100 -4.714% -1.810% 0.450%
iShares Nikkei 225® -2.976% -2.660% 10.156%
iShares S&P 500 -2.744% -0.448% 0.320%

According to BiotechBee what are the pros and cons of Syros Pharmaceuticals Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Syros Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 25.00%
Target price 5.500
Change
Ends at 30.06.27

Buy mit Kursziel 5,5

BiotechBee 
0
Report Share
08.09.24
In the thread Trading Syros Pharmaceuticals Inc
Prediction Buy
Perf. (%) 25.00%
Target price 5.500
Change
Ends at 30.06.27

Buy beendet

BiotechBee 
0
Report Share
29.09.24

Stopped prediction by BiotechBee for Syros Pharmaceuticals Inc.

buy
Syros Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.75
29.09.24
€3.00
31.05.27
1.14%
01.10.24

Could be very worthwhile Investment >20% year
BiotechBee 
29.09.24 50%
buy
Syros Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.67
04.12.23
€4.00
30.11.25
-47.57%
08.09.24

Could be very worthwhile Investment >20% year
BiotechBee 
04.12.23 60%
buy
Syros Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.68
24.06.23
€4.00
31.12.25
36.94%
01.10.23

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 50%